@article{20176fd660fb4e15b6c92cfe72eb5b89,
title = "A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer",
abstract = "Bolus serves as a tissue equivalent material that shifts the 95-100% isodose line towards the skin and subcutaneous tissue. The need for bolus for all breast cancer patients planned for postmastectomy radiation therapy (PMRT) has been questioned. The work was initiated by the faculty of the European SocieTy for Radiotherapy & Oncology (ESTRO) breast cancer courses and represents a multidisciplinary international breast cancer expert collaboration to optimize PMRT. Due to the lack of randomised trials evaluating the benefits of bolus, we designed a stepwise project to evaluate the existing evidence about the use of bolus in the setting of PMRT to achieve an international consensus for the indications of bolus in PMRT, based on the Delphi method. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 115-121",
keywords = "Breast cancer, Mastectomy, Radiation therapy, PMRT, Bolus, Tissue compensator, SKIN-SPARING MASTECTOMY, CLINICAL-PRACTICE GUIDELINES, TARGET VOLUME DELINEATION, CARCINOMA-IN-SITU, LOCAL RECURRENCE, CHEST-WALL, REGIONAL RECURRENCE, PREDICTIVE FACTORS, AMERICAN-SOCIETY, RESIDUAL DISEASE",
author = "O. Kaidar-Person and H.M. Dahn and A.M. Nichol and L.J. Boersma and {de Ruysscher}, D. and I. Meattini and J.P. Pignol and C. Aristei and Y. Belkacemi and D. Benjamin and N. Bese and C.E. Coles and P. Franco and A.Y. Ho and S. Hol and R. Jagsi and A.M. Kirby and L. Marrazzo and G.N. Marta and M.S. Moran and H.D. Nissen and V. Strnad and Y. Zissiadis and P.M. Poortmans and B.V. Offersen",
note = "Funding Information: We thank Alina Markinzon, MA, a medical librarian from Sheba Tel H'ashomer, and Ruth Suhami, MLIS, a medical librarian from Gitter-Smolarz Library of Life Sciences and Medicine Tel Aviv University for performing the literature search. Funding Information: I confirm none have conflict of interest or disclosures relevant for this work. CEC is supported by the NIHR Cambridge BRC. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",
year = "2021",
month = nov,
day = "1",
doi = "10.1016/j.radonc.2021.09.012",
language = "English",
volume = "164",
pages = "115--121",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
}